Adverse effects of radioiodine treatment on salivary glands in differentiated thyroid carcinoma patients
Completed
- Conditions
- inflammation of a salivary gland due to radioiodine therapy10043739sialoadenitis
- Registration Number
- NL-OMON40486
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Age at diagnosis is at least 18 years
2. The patient is awaiting radioiodine ablation therapy following DTC diagnosis, or is in follow-up for DTC and awaiting radioiodine therapy for persistent or recurrent disease
3. The subject gives written informed consent for study participation
Exclusion Criteria
1. A history of Sjögrens syndrome or other salivary gland disease affecting salivary gland function
2. Oral ulceration
3. Patient is mentally incapacitated
4. Patient receives recombinant human TSH (rhTSH) prior to I131 treatment
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method